Meag Munich Ergo, Kapitalanlagegesellschaft Mbh / GILD
Meag Munich Ergo, Kapitalanlagegesellschaft Mbh’s Gilead Sciences Inc Position
Does Meag Munich Ergo, Kapitalanlagegesellschaft Mbh own Gilead Sciences Inc (GILD)? Yes — 632.9K shares worth $70M (+1.98% of its 13F portfolio) as of Q2 2025, up from 474.3K shares the prior filed quarter.
Position Value
$70M
Q2 2025
Shares
632.9K
% of Portfolio
+1.98%
Quarters Held
27
currently held
Position History GILD
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2025 | 632.9K | $70M | +1.98% |
| Q1 2025 | 474.3K | $53M | +1.56% |
| Q4 2024 | 887.9K | $82M | +2.58% |
| Q3 2024 | 933.7K | $78M | +2.46% |
| Q2 2024 | 964.1K | $66M | +2.20% |
| Q1 2024 | 876.9K | $64M | +2.32% |
| Q4 2023 | 885.0K | $72M | +2.72% |
| Q3 2023 | 620.7K | $47M | +2.03% |
| Q2 2023 | 504.8K | $39M | +1.70% |
| Q1 2023 | 20.3K | $2M | +0.08% |
| Q4 2022 | 33.3K | $3M | +0.15% |
| Q3 2022 | 14.8K | $912,000 | +0.06% |
| Q2 2022 | 18.3K | $1M | +0.07% |
| Q1 2022 | 7.5K | $451,000 | +0.03% |
| Q4 2021 | 4.2K | $309,000 | +0.02% |
| Q3 2021 | 4.2K | $293,000 | +0.05% |
| Q2 2021 | 38.9K | $3M | +0.26% |
| Q1 2021 | 56.4K | $4M | +0.37% |
| Q4 2020 | 34.5K | $2M | +0.45% |
| Q3 2020 | 28.5K | $2M | +0.33% |
| Q2 2020 | 20.8K | $2M | +0.30% |
| Q1 2020 | 32.9K | $2M | +0.58% |
| Q4 2019 | 93.6K | $6M | +0.65% |
| Q3 2019 | 130.8K | $8M | +0.42% |
| Q2 2019 | 71.0K | $5M | +0.37% |
| Q1 2019 | 49.4K | $3M | +0.26% |
| Q4 2018 | 98.9K | $6M | +0.77% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Meag Munich Ergo, Kapitalanlagegesellschaft Mbh’s full portfolio or all institutional holders of GILD.